Jun 27, 2012 8:00am EDT Tonix Pharmaceuticals Receives Health Canada Clearance to Study a Novel Treatment for Fibromyalgia
May 10, 2012 9:32pm EDT CORRECTING and REPLACING Tonix Pharmaceuticals Appoints Dr. Samuel Saks to Its Board of Directors
Apr 5, 2012 5:40pm EDT TONIX Pharmaceuticals Completes Pharmacokinetic Study on New Formulation of TNX-102 for Fibromyalgia
Apr 4, 2012 6:04am EDT TONIX Pharmaceuticals Strengthens Management Team with the Appointments of Its New Chief Financial Officer and Senior Director of Drug Development
Mar 6, 2012 6:04am EST TONIX Pharmaceuticals Holding Corp. Closes on Net Proceeds of $2.0 Million in Second Tranche of a $6.6 Million Private Placement
Feb 7, 2012 6:01am EST TONIX Pharmaceuticals to Present at the 14th Annual Bio CEO & Investor Conference on February 14, 2012
